Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Oct 8, 2026, 4:00 PM EDT
1.000
-0.110 (-9.91%)
Pre-market: Oct 9, 2026, 5:17 AM EDT
Radiopharm Theranostics Stock Forecast
RADX's stock price has decreased by -84.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 analysts polled by S&P Global, Radiopharm Theranostics stock has a consensus rating of "Strong Buy" and an average price target of $17.04. The average 1-year stock price forecast is 1,435.14% higher than the current stock price, while the lowest is $12.47 (+1,023.42%) and the highest is $30.09 (+2,610.81%).
Price Target: $17.04 (+1,435.14%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 4, 2026.
Analyst Ratings
The average analyst rating for Radiopharm Theranostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $16 | Buy | Initiates | $16 | +1,341.44% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
6.87M
from 12.87M
Decreased by -46.59%
Revenue Next Year
153.48M
from 6.87M
Increased by 2,133.67%
EPS This Year
-0.07
from -0.09
EPS Next Year
0.00
from -0.07
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.